2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
…, P Dendale, P Dilaveris, H Drexel… - European journal of …, 2022 - Wiley Online Library
Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P.
Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor …
Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor …
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart …
…, JGF Cleland, RA de Boer, H Drexel… - European journal of …, 2019 - Wiley Online Library
The European Society of Cardiology (ESC) has published a series of guidelines on heart
failure (HF) over the last 25 years, most recently in 2016. Given the amount of new information …
failure (HF) over the last 25 years, most recently in 2016. Given the amount of new information …
Brown versus white adipose tissue: a mini-review
CH Saely, K Geiger, H Drexel - Gerontology, 2011 - karger.com
Background: Brown adipose tissue (BAT) is abundant in small mammals and in newborns
and helps them to survive cold temperatures. In adults, it had long been considered to be …
and helps them to survive cold temperatures. In adults, it had long been considered to be …
Gender differences in the effects of cardiovascular drugs
An initiation-promotion protocol was used to test the hypothesis that unleaded gasoline (UG)
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the …
…, JF Tamby, PE Aylward, H Drexel… - The lancet Diabetes & …, 2019 - thelancet.com
Background After acute coronary syndrome, diabetes conveys an excess risk of ischaemic
cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with ezetimibe …
cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with ezetimibe …
Phytochemicals and their impact on adipose tissue inflammation and diabetes
A Leiherer, A Mündlein, H Drexel - Vascular pharmacology, 2013 - Elsevier
Type 2 diabetes mellitus is an inflammatory disease and the mechanisms that underlie this
disease, although still incompletely understood, take place in the adipose tissue of obese …
disease, although still incompletely understood, take place in the adipose tissue of obese …
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular …
…, S Debus, JP Collet, H Drexel… - European Heart …, 2021 - academic.oup.com
The aim of this collaborative document is to provide an update for clinicians on best
antithrombotic strategies in patients with aortic and/or peripheral arterial diseases. Antithrombotic …
antithrombotic strategies in patients with aortic and/or peripheral arterial diseases. Antithrombotic …
The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients
…, T Marte, P Langer, G Hoefle, H Drexel - The Journal of …, 2005 - academic.oup.com
Context: The contribution of insulin resistance per se to the vascular risk conferred by the
metabolic syndrome (MetS) is not known; conversely, it is uncertain whether insulin resistance …
metabolic syndrome (MetS) is not known; conversely, it is uncertain whether insulin resistance …
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control
…, CH Saely, A Muendlein, A Vonbank, H Drexel… - Atherosclerosis, 2015 - Elsevier
Background After ingestion of phosphatidylcholine, l-carnitine or betaine, trimethylamine-N-oxide
(TMAO) is formed by gut microbiota and liver enzymes. Elevated TMAO plasma levels …
(TMAO) is formed by gut microbiota and liver enzymes. Elevated TMAO plasma levels …
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
…, C Vitale, H Schmidt, H Drexel… - European heart …, 2015 - academic.oup.com
Cardiovascular (CV) disease is the leading cause of morbidity and mortality in both sexes in
developed countries, but gender differences exists in its diagnosis and treatment. Since the …
developed countries, but gender differences exists in its diagnosis and treatment. Since the …